Hepatic Encephalopathy Management (AASLD/EASL 2022)
Hepatic Encephalopathy Management (AASLD/EASL 2022): Suspected Hepatic Encephalopathy → Confirm HE Diagnosis → Grade HE Severity (West Haven) → Grade 1:...
Interactive Decision Tree
Algorithm Steps
- ▶Start
Suspected Hepatic Encephalopathy
Patient with chronic liver disease + altered mental status/neurological changes
- ●Action
Confirm HE Diagnosis
Rule out other causes of altered mental status
- Known chronic liver disease/cirrhosis
- Assess for precipitants
- Rule out: hypoglycemia, electrolyte disorders, infection, intracranial pathology, drugs/toxins
- CT head if focal neuro signs or no improvement
- ◆Decision
Grade HE Severity (West Haven)
Determine grade to guide management intensity
- Covert HE: Grade 0-1 (psychometric testing abnormal)
- Overt HE: Grade 2-4 (clinically apparent)
- ●Action
Grade 1: Trivial Lack of Awareness
Shortened attention, sleep disturbance
- May have asterixis on exam
- Start lactulose
- Identify precipitants
- ●Action
Identify & Treat Precipitants
Most episodes have identifiable trigger
- Infection (UTI, SBP, pneumonia) - start antibiotics
- GI bleeding - treat source
- Constipation - lactulose
- Electrolyte disorders (hyponatremia, hypokalemia) - correct
- Dehydration - IV fluids cautiously
- Medications (opioids, benzos) - discontinue
- Dietary protein excess - rare, don't restrict protein
- ●Action
Lactulose (First-Line)
Non-absorbable disaccharide
- Initial: 25-45 mL PO q1-2h until bowel movement
- Maintenance: 25-45 mL PO BID-QID
- Target: 2-3 soft BM/day
- Lactulose enema: 300 mL in 1L water (retain 30-60 min)
- ●Action
Add Rifaximin (Second-Line)
For lactulose failure or recurrence prevention
- 550 mg PO BID
- Continue lactulose (combination therapy)
- Reduces HE recurrence by ~50%
- No significant resistance or systemic absorption
- ◆Decision
Assess Response
Improvement expected within 24-48 hours
- ✓Outcome
HE Resolved
Continue secondary prophylaxis
- Lactulose maintenance (2-3 BM/day)
- Rifaximin 550 mg BID after first overt HE episode
- Optimize nutrition (1.2-1.5 g/kg protein)
- Avoid precipitants
- ⚠Warning
Refractory HE
Consider additional interventions
- Re-evaluate for missed precipitants
- Consider TIPS occlusion if post-TIPS HE
- Liver transplant evaluation
- Zinc supplementation (if deficient)
- L-ornithine L-aspartate (LOLA) - limited evidence
- ●Action
Grade 2: Disorientation, Lethargy
Obvious personality change, inappropriate behavior
- Asterixis present
- Lactulose + precipitant treatment
- Consider admission
- ⚠Warning
Grade 3: Somnolent, Confused
Arousable but marked confusion
- Hospital admission required
- Lactulose NG if unable to take PO
- Close monitoring
- ⚠Warning
⚠️ Grade 4: Coma
ICU admission, consider ALF evaluation
- Intubate for airway protection
- Rule out cerebral edema
- Lactulose enemas if intubated
- Consider transplant evaluation
Guideline Source
AASLD/EASL Practice Guideline on Hepatic Encephalopathy in Chronic Liver Disease
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- West Haven criteria are subjective
- Ammonia levels do not correlate with severity
- Lactulose dosing requires individualization
- Rifaximin cost may limit access
- Must rule out other causes of altered mental status
Applicable Regions
EU: EASL guidelines jointly developed
US: AASLD 2022 is current standard
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Calculator
Glasgow-Blatchford Bleeding Score
Upper GI bleed risk stratification and need for intervention
Compare
AttendMe.ai vs UpToDate
See how this pathway workflow compares against UpToDate.
Commercial
Start free
Run the pathway in a live AttendMe account with citations and tracked usage.
Related Resources
Frequently Asked Questions
What is the Hepatic Encephalopathy Management (AASLD/EASL 2022)?
The Hepatic Encephalopathy Management (AASLD/EASL 2022) is a management clinical algorithm for Gastroenterology. It provides a structured decision tree to guide clinical decision-making, based on AASLD/EASL Practice Guideline on Hepatic Encephalopathy in Chronic Liver Disease.
What guideline is the Hepatic Encephalopathy Management (AASLD/EASL 2022) based on?
This algorithm is based on AASLD/EASL Practice Guideline on Hepatic Encephalopathy in Chronic Liver Disease (DOI: 10.1002/hep.32327).
What are the limitations of the Hepatic Encephalopathy Management (AASLD/EASL 2022)?
Known limitations include: West Haven criteria are subjective; Ammonia levels do not correlate with severity; Lactulose dosing requires individualization; Rifaximin cost may limit access; Must rule out other causes of altered mental status. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Hepatic Encephalopathy Management (AASLD/EASL 2022) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free